| Professional Services Industry | Industrials Sector | Mr. Zheng Wang CEO | SSE Exchange | CNE1000030C3 ISIN |
| CN Country | 1,406 Employees | 18 Jun 2020 Last Dividend | 25 Apr 2018 Last Split | - IPO Date |
Thalys Medical Technology Group Corporation, originally founded in 2004, has established itself as a key player in China's medical inspection industry. Initially known as Thalys Medical Technology Inc., the company underwent a name change in September 2020 to its current designation, reflecting its evolution and growth in scope. The company's headquarters are located in Wuhan, China, signifying its central role in the bustling medical technology sector of one of the largest markets in the world. Specializing in intensive operation services of medical inspection, Thalys Medical Technology Group Corporation has carved out a niche for itself, catering to a crucial aspect of healthcare that ensures the accuracy and efficiency of medical diagnostics and research.
Thalys Medical Technology Group Corporation boasts an extensive range of products and services tailored to meet the diverse needs of the medical inspection industry: